Report: Screening programs in Italy (Italy)

forpolicymakers italycountry Go back to Italy page

Primary purpose: Assesses annual cancer screening programs in Italy, indicating substantial participation in mammography and cervical screenings, significant progress in colorectal screening, and disparities in coverage between regions.

Sponsor, manager or home institution: Osservatorio Nazionale Screening; Ministero della Salute.

Type of information: Effective extent of mammography, cervical and colorectal screening; Participation (%) in screenings according to the country of origin; Waiting times; Invitations; Availability of pre-operative diagnosis; Conservative surgery; Total number of persons invited; Number of persons participating in the invitation; Acceptance of the invitation; Number of persons examined in the period; Proportion of persons recalled for further investigation; Benign biopsies; Cancer identification rate; Invasive cancer identification rate; Percentage of conservative surgical treatment in invasive tumours; Mammography performed within the last 2 years; Fecal occult blood test programs - Main results in the two-year period; Programs with Rectosigmoidoscopy; Examination for the prevention of colorectal cancer in the recommended times (%) persons; Lesions with CIN2+ histology identified; Introduction of the human papilloma virus (Hpv) test as a screening test; Preventive test coverage in the last 3 years.

Data level: national level and regional level.

Cancer areas of interest: C15-C26: Digestive system cancers, C50: Breast cancer and C51-C58: Female genitalia cancer. Click here to learn more.

Access to information: Click here to access.

Esophagus Stomach Small intestine Large intestine Rectum Anus Liver Gallbladder Bile ducts Pancreas Colon Lobular Breast Nipple Areola Ductal Vulva Vagina Cervix Uterus Ovary Fallopian tubes Endometrium dataOwner::Osservatorio Nazionale Screening dataOwner::Ministero della Salute availableVariable::screening availableVariable::region|country availableVariable::diagnosis availableVariable::medical procedures|Conservative surgery availableVariable::year dataLevel::national level dataLevel::regional level hasCancerType::C15-C26: Digestive system cancers hasCancerType::C50: Breast cancer hasCancerType::C51-C58: Female genitalia cancer isReport hasCancerType::C00-D48: All neoplasms hasCancerType::C00-C97: All cancer types hasCancerType::C00-C14: Mouth/throat cancers hasCancerType::C30-C39: Lung/chest cancers hasCancerType::C40-C41: Bone cancers hasCancerType::C43-C44: Skin cancers/melanoma hasCancerType::C45-C49: Soft tissue cancer hasCancerType::C51-C58: Female genitalia cancers hasCancerType::C60-C63: Male genitalia cancer hasCancerType::C64-C68: Urinary system cancers hasCancerType::C69-C72: Eye and brain cancer hasCancerType::C73-C75: Thyroid and other gland cancers hasCancerType::C76-C80: Cancers of unknown or unspecified areas hasCancerType::C81-C96: Cancers of the blood and immune system hasCancerType::C97-C97: Cancers in multiple locations from the start hasCancerType::D00-D09: Early-stage cancers not yet spread hasCancerType::D10-D36: Benign tumour hasCancerType::D37-D48: Growths of uncertain nature hasCancerType::unknown